Merz Therapeutics: Merz Enters Asset Purchase Agreement With a US-Based Biotech Company finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Merz Therapeutics a business of Frankfurtbased Merz Group has entered into an Asset Purchase Agreement to acquire two commercial medicines from NASDAQlisted Acorda Therapeutics.
Merz Enters Asset Purchase Agreement With a US-Based Biotech Company streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Mexico City, London, and now Frankfurt am Main, Germany: Experienced Pharma manager appointed to lead Merz Therapeutics As of immediately, Stefan König will be responsible for Merz Therapeutics
Mexico City, London, and now Frankfurt am Main, Germany: Experienced Pharma manager appointed to lead Merz TherapeuticsFRANKFURT AM MAIN, Germany (BUSINESS WIRE) As of immediately, Stefan König will be responsible for Merz Therapeutics GmbH as CEO and Managing Director. As one of the businesses of Merz Group, Merz.